Founded in 1989, CPC Clinical Research is recognized for its expertise in comprehensive trial management for both national and international clinical research. CPC Clinical Research is led by Dr. William Hiatt, an internationally recognized specialist in vascular medicine and professor of Medicine at the University of Colorado. Dr Hiatt has extensive experience in the design and management of global cardiovascular clinical trials as well as a decade long history of regulatory experience as panel member and Chairman of the FDA's Cardio-Renal Advisory Committee. CPC's Clinical Research leadership complements this experience with over 40 years of collective industry, government and academic-sponsored clinical trial development and operations experience.
CPC Clinical Research provides leadership in the design and oversight of clinical trials in partnership with our Sponsors. We strive to maximize the success of every clinical trial by integrating sound clinical science, rigorous endpoint training and data collection, and Steering Committee leadership.
The result of this program is an efficient, effective clinical trial with the highest potential for successful and conclusive determination of trial results. Our demonstrated ability to control endpoint variability translates into more definitive signals, thereby minimizing trial sample sizes, which lowers overall trial costs. Critical to its success, EQuIP includes site quality programs, which include tailored training videos and reference tools designed to optimize trial conduct and endpoint collection. One key element of this program are regular on-site quality interventions with site staff, which focuses on the site staff's ability to properly acquire complete and accurate data. CPC Clinical Research's full service management, combined with EQuIP, provides a cost-effective, innovative solution.